Picture loading failed.

Anti-IL36RN therapeutic antibody (Pre-made Spesolimab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Spesolimab (BI 655130) is a humanised monoclonal antibody being developed by Boehringer Ingelheim, for the treatment of generalised pustular psoriasis, Crohn's disease, palmoplantar pustulosis, ulcerative colitis and atopic dermatitis.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-532-1mg 1mg 3090
GMP-Bios-ab-532-10mg 10mg 21890
GMP-Bios-ab-532-100mg 100mg 148000
GMP-Bios-ab-532-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-IL36RN therapeutic antibody (Pre-made Spesolimab biosimilar,Whole mAb)
INN Name Spesolimab
TargetIL36RN
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusActive
100% SI Structure6u6u:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
Companiesna
Conditions Approvedna
Conditions ActiveUlcerative colitis;Atopic dermatitis;Crohn's disease;Palmoplantar pustulosis;Pustular psoriasis
Conditions Discontinuedna
Development Techna